05.03.2015 15:56:00

Quest Diagnostics Incorporated -- Moody's rates Quest's proposed sr. notes Baa2

New York, March 05, 2015 -- Moody's Investors Service assigned a Baa2 rating to Quest Diagnostics Incorporated's (Quest) proposed offering of a total of $1.2 billion senior unsecured notes due 2020, 2025 and 2045. Moody's does not expect a meaningful change in Quest's leverage given the intended use of proceeds. The stable rating outlook is unchanged.

Vollständigen Artikel bei Moodys lesen